STEPHANIE OLSEN: Open Payments
NPI 1912542051 · ROCHESTER, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$823 in 48 payments from 13 companies in 2025. Trend: 2023 $679 · 2024 $1,274 · 2025 $823
Food & beverage: $823
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 12 | $210 |
| Novo Nordisk Inc | 10 | $167 |
| AstraZeneca Pharmaceuticals LP | 6 | $108 |
| Teva Pharmaceuticals USA, Inc. | 4 | $68 |
| Aimmune Therapeutics, Inc. | 4 | $65 |
| PFIZER INC. | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Amgen Inc. | 2 | $36 |
| Abbott Laboratories | 2 | $32 |
| Exact Sciences Corporation | 1 | $17 |
Products named: MOUNJARO, Ozempic, JARDIANCE, AUSTEDO XR, ZENPEP, Wegovy, FARXIGA, AIRSUPRA.
Industry payments across IL — which companies pay providers there.
